Clinical Trial Update: Individualised Versus Standard Care for Breast Cancer Patients at High-risk for Chemotherapy-induced Nausea and Vomiting The ILIAD Study [Phase 3]

View source ↗

Summary

Phase 3 trial comparing individualized versus standard care to reduce chemotherapy-induced nausea and vomiting in high-risk breast cancer patients; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED